STOCK TITAN

DRDGOLD LTD (DRDGF) SEC Filings

DRDGF OTC Link

Welcome to our dedicated page for DRDGOLD SEC filings (Ticker: DRDGF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on DRDGOLD's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into DRDGOLD's regulatory disclosures and financial reporting.

Filing
Rhea-AI Summary

DRDGOLD LTD (DRD) reports that officer Moloto Kgabo exercised 11,586 Deferred Shares on August 13, 2026, which vested under the Company’s Single Incentive Plan and were settled one-for-one into Ordinary Shares for no consideration. The same 11,586 Ordinary Shares were then sold in a pooled sale on August 31 and September 1, 2026 at an average price of $2.7545 per share, converted from ZAR 44.4764 per share. Following these transactions, Kgabo holds 62,002 Deferred Shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

DRDGOLD LTD (DRD) reports that Chief Operating Officer Jacobus Schoeman exercised equity awards and sold shares. On August 13, 2026, 19,403 Deferred Shares previously awarded under the Company’s Single Incentive Plan vested and were settled on a one-for-one basis into Ordinary Shares for no consideration. A pooled sale on Schoeman’s behalf then disposed of 19,403 Ordinary Shares on August 31 and September 1, 2026 at an average price of $2.7545 per share, converted from South African rand. Following related activity previously reported, Schoeman holds 166,169 Deferred Shares. No Rule 10b5-1 trading plan is indicated.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

DRDGOLD LTD (DRD) reported that officer Henry Gouws, Head of Production and Director of Ergo, exercised and settled 16,826 Deferred Shares into the same number of Ordinary Shares on August 13, 2026 at no cost under the company’s Single Incentive Plan, then sold 16,826 Ordinary Shares in market transactions on August 31 and September 1, 2026 at an average price of about $2.75 per share, converted from South African rand. Following these transactions, he continues to hold 144,077 Deferred Shares. No Rule 10b5-1 trading plan is indicated.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

DRDGOLD LTD (DRD) reported that Dean Lindecke, General Manager Ergo Ops., had 20,060 deferred shares granted under the Company’s Single Incentive Plan vest on August 13, 2026 and settle one-for-one into Ordinary Shares for no consideration.

Following this vesting, 20,060 Ordinary Shares were sold on the reporting person’s behalf in a pooled sale conducted on August 31 and September 1, 2026 at an average price of $2.7545 per share, translated from an average sale price of ZAR 44.4764 per share. After these transactions, the reporting person held 94,415 deferred shares, with no Rule 10b5-1 trading plan reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

DRDGOLD LTD (DRD) reported that Financial Manager FWGR Ops. Laas Lihan exercised and sold equity-based awards. On August 13, 2026, 9,029 Deferred Shares vested and were settled one-for-one into Ordinary Shares for no consideration under the Single Incentive Plan. A pooled sale then disposed of 9,029 Ordinary Shares on August 31 and September 1, 2026 at an average of $2.7545 (ZAR 44.4764) per share. No Rule 10b5-1 trading plan is reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

DRDGOLD LTD (DRD) reports that officer Mashatola Mpho exercised 11,721 Deferred Shares on August 13, 2026, which vested under the Company’s Single Incentive Plan and were settled one-for-one into Ordinary Shares for no consideration. A subsequent pooled sale on August 31 and September 1, 2026 disposed of 5,275 Ordinary Shares, with the remaining 6,446 Ordinary Shares retained in the reporting person’s own name. Following these events, the reporting person holds 72,900 Deferred Shares; no Rule 10b5-1 trading plan is reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

DRDGOLD LTD (DRD) insider Daniel Pretorius, the Chief Executive Officer and a director, reported transactions involving 35,537 shares linked to previously awarded Deferred Shares. On August 13, 2026, 35,537 Deferred Shares vested and were settled one-for-one into Ordinary Shares for no consideration, and a pooled sale of 35,537 Ordinary Shares was later conducted on August 31 and September 1, 2026 at an average price of $2.7545 per share equivalent to ZAR 44.4764. No Rule 10b5-1 trading plan is reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

DRDGOLD Limited (DRD) reports dealings in its securities following the vesting of deferred share awards under its Single Incentive Plan and Deferred Share Plan. On August 13, 2026, a portion of awards granted on August 12, 2025 vested and was settled in DRDGOLD ordinary shares at a zero-exercise price.

Certain participants, including executive directors, a prescribed officer, the company secretary and directors of major subsidiaries, elected to sell all or part of their vested shares through a pooled on‑market sale conducted by an independent third party on August 31 and September 1, 2026. Proceeds were distributed to each participant in proportion to the number of DRDGOLD shares sold, with prior clearance to deal obtained from the board chairman and interests described as direct beneficial.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

DRDGOLD Limited (DRD) reports planned changes to its Audit Committee leadership aligned with its 2026 Annual General Meeting (2026 AGM). Non-executive director Johan Holtzhausen will step down from the board at the conclusion of the 2026 AGM, following a previously communicated tenure review.

The board has resolved that Charmel Flemming, an independent non-executive director since 1 August 2020, will become chair of the Audit Committee from the conclusion of the 2026 AGM. She is a Chartered Accountant with more than 15 years’ experience in financial services, and the board states it is satisfied she has the qualifications and expertise to discharge the responsibilities of Audit Committee chair.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

DRDGOLD Limited (DRD) reports that, under its Single Incentive Plan incorporating the Deferred Share Plan (DSP), several directors, prescribed officers and the company secretary have accepted annual deferred share awards. The awards carry a zero exercise price and are settled in DRDGOLD ordinary shares on vesting, subject to continued employment and DSP rules. The deemed price per DRDGOLD share for these awards is R36.15, based on the 7‑trading‑day volume weighted average price on the award date of 12 August 2026. Key participants include CEO Niël Pretorius with 163,530 deferred shares (vesting 12 August 2031) and CFO Henriette Hooijer with 74,019 deferred shares (also vesting 12 August 2031), alongside other senior executives and officers with vesting dates in 2029 or 2031.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

How many DRDGOLD (DRDGF) SEC filings are available on StockTitan?

StockTitan tracks 58 SEC filings for DRDGOLD (DRDGF), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for DRDGOLD (DRDGF)?

The most recent SEC filing for DRDGOLD (DRDGF) was filed on September 3, 2026.